MetaADEDB 2.0 @ LMMD
pazopanib
(CUIHSIWYWATEQL-UHFFFAOYSA-N)
Structure
SMILES
CN(c1ccc2c(c1)nn(c2C)C)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N)C
Type(s)
Approved
ATC code(s)
L01XE11
Molecular Formula:
C21H23N7O2S
Molecular Weight:
437.518
Log P:
4.9931
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
2
TPSA:
127.41
CAS Number(s):
444731-52-6; 790713-33-6
Synonym(s)
1.
pazopanib
2.
GW 780604
3.
GW 786034B
4.
GW-780604
5.
GW-786034B
6.
GW780604
7.
GW786034B
8.
Votrient
External Link(s)
MeSHC516667
PubChem Compound10113978
BindingDB26474
ChEBI71219
CHEMBLCHEMBL477772
DrugBankDB06589
DrugCentral4118
IUPHAR/BPS Guide to PHARMACOLOGY5698
KEGGdr:D05380
ZINC11617039
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Malignant neoplasm progressionFAERS: 73
Canada Vigilance: 1
Canada Vigilance
US FAERS
2FatigueFAERS: 67SIDER
US FAERS
3NauseaFAERS: 60SIDER
US FAERS
4Alanine Aminotransferase IncreasedFAERS: 47
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
5Disease ProgressionFAERS: 40US FAERS
6AstheniaFAERS: 38SIDER
US FAERS
7VomitingFAERS: 37SIDER
US FAERS
8Abdominal PainFAERS: 36SIDER
US FAERS
9MalaiseFAERS: 35US FAERS
10Aspartate Aminotransferase IncreasedFAERS: 34SIDER
US FAERS
11DehydrationFAERS: 32SIDER
US FAERS
12HepatotoxicityFAERS: 32
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
13ThrombocytopeniaFAERS: 32SIDER
US FAERS
14PainFAERS: 28SIDER
US FAERS
15PneumoniaFAERS: 28US FAERS
16SepsisFAERS: 23US FAERS
17General physical health deteriorationFAERS: 22US FAERS
18Pulmonary EmbolismFAERS: 21SIDER
US FAERS
19HeadacheFAERS: 20SIDER
US FAERS
20Gamma-Glutamyltransferase IncreasedFAERS: 19SIDER
US FAERS
21Product use in unapproved indicationFAERS: 19US FAERS
22jaundiceFAERS: 19SIDER
US FAERS
23Deep Vein ThrombosisFAERS: 16SIDER
US FAERS
24Pericardial effusionFAERS: 15US FAERS
25Weight decreasedFAERS: 15SIDER
US FAERS
26Blood creatinine increasedFAERS: 14SIDER
US FAERS
27HypersensitivityFAERS: 14US FAERS
28HypothyroidismFAERS: 14SIDER
US FAERS
29PneumothoraxFAERS: 14SIDER
US FAERS
30InfectionFAERS: 13SIDER
US FAERS
31ProteinuriaFAERS: 13SIDER
US FAERS
32Toxicity to various agentsFAERS: 13US FAERS
33ColitisFAERS: 12US FAERS
34HyperthyroidismFAERS: 12US FAERS
35IleusFAERS: 12US FAERS
36Back PainFAERS: 11US FAERS
37Cerebral InfarctionFAERS: 11SIDER
US FAERS
38ConstipationFAERS: 11US FAERS
39Intestinal ObstructionFAERS: 11US FAERS
40Skin UlcerFAERS: 11SIDER
US FAERS
41Urinary tract infectionFAERS: 11US FAERS
42AscitesFAERS: 10US FAERS
43Duodenal UlcerFAERS: 10US FAERS
44Acute kidney injuryFAERS: 9US FAERS
45Blood alkaline phosphatase increasedFAERS: 9SIDER
US FAERS
46Flank PainFAERS: 9US FAERS
47Hypertensive crisisFAERS: 9SIDER
US FAERS
48HypotensionFAERS: 9US FAERS
49PancreatitisFAERS: 9SIDER
US FAERS
50Respiratory FailureFAERS: 9US FAERS
51DysgeusiaFAERS: 8SIDER
US FAERS
52Febrile NeutropeniaFAERS: 8US FAERS
53GastritisFAERS: 8US FAERS
54LethargyFAERS: 8SIDER
US FAERS
55NeutropeniaFAERS: 8SIDER
US FAERS
56PruritusFAERS: 8SIDER
US FAERS
57Renal Cell CarcinomaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
58Tumour haemorrhageFAERS: 8US FAERS
59ArthralgiaFAERS: 7SIDER
US FAERS
60Electrolyte imbalanceFAERS: 7US FAERS
61EpilepsyFAERS: 7US FAERS
62MyalgiaFAERS: 7SIDER
US FAERS
63SomnolenceFAERS: 7SIDER
US FAERS
64Transaminases increasedFAERS: 7US FAERS
65Abdominal discomfortFAERS: 6US FAERS
66Atrial FibrillationFAERS: 6US FAERS
67DisorientationFAERS: 6US FAERS
68DizzinessFAERS: 6SIDER
US FAERS
69EosinophiliaFAERS: 6US FAERS
70MetastasisFAERS: 6US FAERS
71Myocardial InfarctionFAERS: 6SIDER
US FAERS
72Nephrotic SyndromeFAERS: 6US FAERS
73Posterior reversible encephalopathy syndromeFAERS: 6SIDER
US FAERS
74StomatitisFAERS: 6SIDER
US FAERS
75TachycardiaFAERS: 6US FAERS
76Visual ImpairmentFAERS: 6US FAERS
77BradycardiaFAERS: 5SIDER
US FAERS
78Cerebrovascular accidentFAERS: 5SIDER
US FAERS
79ChillsFAERS: 5SIDER
US FAERS
80Concomitant disease aggravatedFAERS: 5US FAERS
81DyspepsiaFAERS: 5SIDER
US FAERS
82EmbolismFAERS: 5SIDER
US FAERS
83Emotional distressFAERS: 5US FAERS
84EpistaxisFAERS: 5SIDER
US FAERS
85HypoxiaFAERS: 5US FAERS
86Intestinal PerforationFAERS: 5SIDER
US FAERS
87Metastatic Renal Cell CarcinomaFAERS: 5US FAERS
88NecrosisFAERS: 5US FAERS
89Osteonecrosis of JawFAERS: 5US FAERS
90Performance status decreasedFAERS: 5US FAERS
91PneumonitisFAERS: 5US FAERS
92SyncopeFAERS: 5SIDER
US FAERS
93Urinary IncontinenceFAERS: 5US FAERS
94Acute myocardial infarctionFAERS: 4US FAERS
95Angina PectorisFAERS: 4US FAERS
96CardiotoxicityFAERS: 4US FAERS
97CellulitisFAERS: 4US FAERS
98CholecystitisFAERS: 4US FAERS
99Compulsive lip bitingFAERS: 4US FAERS
100DuodenitisFAERS: 4US FAERS
101EnterocolitisFAERS: 4US FAERS
102Enterocutaneous FistulaFAERS: 4SIDER
US FAERS
103ErythemaFAERS: 4SIDER
US FAERS
104HepatitisFAERS: 4US FAERS
105Mental status changesFAERS: 4US FAERS
106Night sweatsFAERS: 4US FAERS
107PalpitationsFAERS: 4US FAERS
108PancytopeniaFAERS: 4US FAERS
109Pleuritic painFAERS: 4US FAERS
110Respiratory distressFAERS: 4US FAERS
111Skin lesionFAERS: 4US FAERS
112Skin necrosisFAERS: 4US FAERS
113Tongue bitingFAERS: 4US FAERS
114leiomyosarcomaFAERS: 4US FAERS
115Abdominal sepsisFAERS: 3US FAERS
116Amylase increasedFAERS: 3SIDER
US FAERS
117Atrial FlutterFAERS: 3US FAERS
118Blood thyroid stimulating hormone increasedFAERS: 3SIDER
US FAERS
119Bone painFAERS: 3US FAERS
120Central nervous system lesionFAERS: 3US FAERS
121Chest discomfortFAERS: 3US FAERS
122CholangitisFAERS: 3US FAERS
123Cytokine Release SyndromeFAERS: 3US FAERS
124Cytolytic hepatitisFAERS: 3US FAERS
125Disseminated Intravascular CoagulationFAERS: 3US FAERS
126Drug ineffectiveFAERS: 3US FAERS
127DysarthriaFAERS: 3US FAERS
128DysphoniaFAERS: 3SIDER
US FAERS
129Ejection Fraction DecreasedFAERS: 3US FAERS
130EnteritisFAERS: 3US FAERS
131HemiparesisFAERS: 3US FAERS
132HydronephrosisFAERS: 3US FAERS
133LymphadenopathyFAERS: 3US FAERS
134Metastases to pelvisFAERS: 3US FAERS
135Metastatic NeoplasmFAERS: 3US FAERS
136Neck PainFAERS: 3US FAERS
137Peripheral swellingFAERS: 3US FAERS
138PeritonitisFAERS: 3SIDER
US FAERS
139PharyngotonsillitisFAERS: 3US FAERS
140PleurisyFAERS: 3US FAERS
141PolyneuropathyFAERS: 3US FAERS
142Pyoderma GangrenosumFAERS: 3US FAERS
143Sinus TachycardiaFAERS: 3US FAERS
144Spinal column stenosisFAERS: 3US FAERS
145Therapy cessationFAERS: 3US FAERS
146ThrombosisFAERS: 3SIDER
US FAERS
147UlcerFAERS: 3US FAERS
148Urinary RetentionFAERS: 3US FAERS
149UrticariaFAERS: 3US FAERS
150VertigoFAERS: 3US FAERS
151Vitreous floatersFAERS: 3US FAERS
152Abdominal massFAERS: 2US FAERS
153Abdominal rigidityFAERS: 2US FAERS
154AbscessFAERS: 2US FAERS
155Acute Coronary SyndromeFAERS: 2SIDER
US FAERS
156AgitationFAERS: 2US FAERS
157AlopeciaFAERS: 2SIDER
US FAERS
158AphagiaFAERS: 2US FAERS
159AphasiaFAERS: 2US FAERS
160ArthritisFAERS: 2US FAERS
161Bilirubin conjugated increasedFAERS: 2US FAERS
162Blood amylase increasedFAERS: 2US FAERS
163Brain natriuretic peptide abnormalFAERS: 2US FAERS
164Cardiac TamponadeFAERS: 2US FAERS
165Cell DeathFAERS: 2US FAERS
166CementoplastyFAERS: 2US FAERS
167CholelithiasisFAERS: 2US FAERS
168ChromaturiaFAERS: 2US FAERS
169Colonic fistulaFAERS: 2US FAERS
170Culture positiveFAERS: 2US FAERS
171DermatitisFAERS: 2SIDER
US FAERS
172Drug resistanceFAERS: 2US FAERS
173Gastric ulcerFAERS: 2US FAERS
174Gastrointestinal obstructionFAERS: 2US FAERS
175Gastrointestinal toxicityFAERS: 2US FAERS
176Gastrointestinal wall thickeningFAERS: 2US FAERS
177HaematotoxicityFAERS: 2US FAERS
178HemiplegiaFAERS: 2US FAERS
179Hypertensive EncephalopathyFAERS: 2US FAERS
180HypophagiaFAERS: 2US FAERS
181Incisional herniaFAERS: 2US FAERS
182InflammationFAERS: 2US FAERS
183Large intestine perforationFAERS: 2SIDER
US FAERS
184Liposarcoma recurrentFAERS: 2US FAERS
185Lower respiratory tract infectionFAERS: 2US FAERS
186Lung AbscessFAERS: 2US FAERS
187MonoplegiaFAERS: 2US FAERS
188MyocarditisFAERS: 2US FAERS
189NasopharyngitisFAERS: 2SIDER
US FAERS
190Neutrophil count decreasedFAERS: 2SIDER
US FAERS
191Oral painFAERS: 2US FAERS
192PallorFAERS: 2US FAERS
193Palpable purpuraFAERS: 2US FAERS
194Pelvic venous thrombosisFAERS: 2US FAERS
195Peritonsillar AbscessFAERS: 2US FAERS
196Pneumatosis intestinalisFAERS: 2US FAERS
197Pneumocystis jiroveci pneumoniaFAERS: 2US FAERS
198PresyncopeFAERS: 2US FAERS
199PurpuraFAERS: 2US FAERS
200Renal cancer metastaticFAERS: 2US FAERS
201Renal massFAERS: 2US FAERS
202Septic ShockFAERS: 2US FAERS
203Serratia test positiveFAERS: 2US FAERS
204Sinus bradycardiaFAERS: 2SIDER
US FAERS
205SinusitisFAERS: 2US FAERS
206Skin toxicityFAERS: 2US FAERS
207Soft tissue massFAERS: 2US FAERS
208SuperinfectionFAERS: 2US FAERS
209Synovial sarcoma metastaticFAERS: 2US FAERS
210Therapy non-responderFAERS: 2US FAERS
211Thoracic vertebral fractureFAERS: 2US FAERS
212Thrombosis in deviceFAERS: 2US FAERS
213VIIth nerve paralysisFAERS: 2US FAERS
214White blood cell count decreasedFAERS: 2SIDER
US FAERS
215Wound InfectionFAERS: 2US FAERS
216Wound dehiscenceFAERS: 2US FAERS
217Wound sepsisFAERS: 2US FAERS
218treatment failureFAERS: 2US FAERS
219Abdominal tendernessFAERS: 1US FAERS
220Abscess soft tissueFAERS: 1US FAERS
221Accessory spleenFAERS: 1US FAERS
222Acute sinusitisFAERS: 1US FAERS
223Adnexa uteri massFAERS: 1US FAERS
224Adrenal massFAERS: 1US FAERS
225AkinesiaFAERS: 1US FAERS
226Alveolar Soft Part SarcomaFAERS: 1US FAERS
227AmnesiaFAERS: 1US FAERS
228Anal FistulaFAERS: 1US FAERS
229Anal abscessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
230Anaphylactic shockFAERS: 1US FAERS
231Aortic AneurysmFAERS: 1US FAERS
232AppendicitisFAERS: 1US FAERS
233ArteriosclerosisFAERS: 1US FAERS
234AtaxiaFAERS: 1US FAERS
235AtelectasisFAERS: 1US FAERS
236Atrial natriuretic peptide increasedFAERS: 1US FAERS
237Atrioventricular BlockFAERS: 1US FAERS
238Bacillus infectionFAERS: 1US FAERS
239Bile Duct StenosisFAERS: 1US FAERS
240Blood bilirubin unconjugated increasedFAERS: 1US FAERS
241Blood cholesterol increasedFAERS: 1US FAERS
242Blood count abnormalFAERS: 1US FAERS
243Blood creatine phosphokinase increasedFAERS: 1US FAERS
244Blood lactate dehydrogenase increasedFAERS: 1US FAERS
245Blood potassium increasedFAERS: 1SIDER
US FAERS
246Blood pressure fluctuationFAERS: 1US FAERS
247Blood urea increasedFAERS: 1SIDER
US FAERS
248Bone erosionFAERS: 1US FAERS
249Bone lesionFAERS: 1US FAERS
250Bone marrow infiltrationFAERS: 1US FAERS
251Bronchial FistulaFAERS: 1US FAERS
252Bronchial ObstructionFAERS: 1US FAERS
253Bronchial dysplasiaFAERS: 1US FAERS
254Bronchopleural FistulaFAERS: 1US FAERS
255Cancer PainFAERS: 1US FAERS
256CandidiasisFAERS: 1US FAERS
257Cardiac dysfunctionFAERS: 1US FAERS
258Cardiac ventricular thrombosisFAERS: 1US FAERS
259CardiomegalyFAERS: 1US FAERS
260Cataract operationFAERS: 1US FAERS
261CataractFAERS: 1US FAERS
262Chest PainFAERS: 1SIDER
US FAERS
263CholestasisFAERS: 1US FAERS
264ChondrosarcomaFAERS: 1US FAERS
265ChordomaFAERS: 1US FAERS
266Clear Cell Sarcoma of Soft TissueFAERS: 1US FAERS
267Clostridium difficile colitisFAERS: 1US FAERS
268Clostridium difficile infectionFAERS: 1US FAERS
269Compression fractureFAERS: 1US FAERS
270Concomitant disease progressionFAERS: 1US FAERS
271CyanosisFAERS: 1US FAERS
272CystitisFAERS: 1US FAERS
273CytopeniaFAERS: 1US FAERS
274Depressed moodFAERS: 1US FAERS
275Dermatitis acneiformFAERS: 1US FAERS
276Device dislocationFAERS: 1US FAERS
277Diabetes MellitusFAERS: 1US FAERS
278Diabetes mellitus inadequate controlFAERS: 1US FAERS
279Diaphragmatic HerniaFAERS: 1US FAERS
280DiplopiaFAERS: 1US FAERS
281DiscomfortFAERS: 1US FAERS
282Disease recurrenceFAERS: 1US FAERS
283Diverticular perforationFAERS: 1US FAERS
284DiverticulitisFAERS: 1US FAERS
285Drug administered to patient of inappropriate ageFAERS: 1US FAERS
286Drug effect incompleteFAERS: 1US FAERS
287Drug level increasedFAERS: 1US FAERS
288Dry skinFAERS: 1SIDER
US FAERS
289Duodenal ObstructionFAERS: 1US FAERS
290DysuriaFAERS: 1US FAERS
291Electrocardiogram changeFAERS: 1US FAERS
292Endothelial dysfunctionFAERS: 1US FAERS
293Enterococcus test positiveFAERS: 1US FAERS
294Erythema MultiformeFAERS: 1US FAERS
295Escherichia infectionFAERS: 1US FAERS
296Exposure via body fluidFAERS: 1US FAERS
297Eye painFAERS: 1US FAERS
298Factor XII DeficiencyFAERS: 1US FAERS
299Feeling abnormalFAERS: 1US FAERS
300Femoral artery occlusionFAERS: 1US FAERS
301Fistula dischargeFAERS: 1US FAERS
302Fistula of small intestineFAERS: 1US FAERS
303FlatulenceFAERS: 1SIDER
US FAERS
304FlushingFAERS: 1SIDER
US FAERS
305Gamma-glutamyltransferase abnormalFAERS: 1US FAERS
306Gastrointestinal perforationFAERS: 1SIDER
US FAERS
307General physical condition abnormalFAERS: 1US FAERS
308GlioblastomaFAERS: 1US FAERS
309GlomerulonephritisFAERS: 1US FAERS
310Hepatic EncephalopathyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
311HydrocephalusFAERS: 1US FAERS
312HyperlipasaemiaFAERS: 1US FAERS
313HypertransaminasaemiaFAERS: 1US FAERS
314Inadequate analgesiaFAERS: 1US FAERS
315Internal injuryFAERS: 1US FAERS
316Intestinal metastasisFAERS: 1US FAERS
317Intra-abdominal fluid collectionFAERS: 1US FAERS
318LaryngitisFAERS: 1US FAERS
319Left Ventricular HypertrophyFAERS: 1US FAERS
320LeukocytosisFAERS: 1US FAERS
321LichenificationFAERS: 1US FAERS
322Lipase increasedFAERS: 1SIDER
US FAERS
323Lobar PneumoniaFAERS: 1US FAERS
324LymphadenitisFAERS: 1US FAERS
325Lymphocyte count decreasedFAERS: 1US FAERS
326Lymphocytic infiltrationFAERS: 1US FAERS
327LymphopeniaFAERS: 1SIDER
US FAERS
328MalabsorptionFAERS: 1US FAERS
329Malignant HypertensionFAERS: 1US FAERS
330MalnutritionFAERS: 1SIDER
US FAERS
331MeningitisFAERS: 1US FAERS
332Mental FatigueFAERS: 1US FAERS
333Mesenteric neoplasmFAERS: 1US FAERS
334MesotheliomaFAERS: 1US FAERS
335Metabolic acidosisFAERS: 1US FAERS
336Metastases to abdominal cavityFAERS: 1US FAERS
337MetrorrhagiaFAERS: 1SIDER
US FAERS
338MonoparesisFAERS: 1US FAERS
339Musculoskeletal PainFAERS: 1SIDER
US FAERS
340NephrolithiasisFAERS: 1US FAERS
341NeuroblastomaFAERS: 1US FAERS
342NoduleFAERS: 1US FAERS
343Non-cardiac chest painFAERS: 1US FAERS
344Ocular cancer metastaticFAERS: 1US FAERS
345Oral mucosal eruptionFAERS: 1US FAERS
346Oropharyngeal painFAERS: 1SIDER
US FAERS
347OsteolysisFAERS: 1US FAERS
348OsteomyelitisFAERS: 1US FAERS
349OverdoseFAERS: 1US FAERS
350Palmar erythemaFAERS: 1US FAERS
351Pancreatic FistulaFAERS: 1US FAERS
352Pancreatic leakFAERS: 1US FAERS
353Pancreatic toxicityFAERS: 1US FAERS
354Paranasal sinus hypersecretionFAERS: 1US FAERS
355ParanoiaFAERS: 1US FAERS
356ParaplegiaFAERS: 1US FAERS
357ParesisFAERS: 1US FAERS
358ParotitisFAERS: 1US FAERS
359Pathological fractureFAERS: 1US FAERS
360Pelvic PainFAERS: 1US FAERS
361Pelvic abscessFAERS: 1US FAERS
362Pelvic massFAERS: 1US FAERS
363PemphigusFAERS: 1US FAERS
364Peripancreatic fluid collectionFAERS: 1US FAERS
365Peripheral arterial occlusive diseaseFAERS: 1US FAERS
366Peripheral motor neuropathyFAERS: 1US FAERS
367PharyngitisFAERS: 1US FAERS
368Physical deconditioningFAERS: 1US FAERS
369Pleurocutaneous fistulaFAERS: 1US FAERS
370PneumoperitoneumFAERS: 1US FAERS
371Portal venous gasFAERS: 1US FAERS
372Post procedural swellingFAERS: 1US FAERS
373Prescribed underdoseFAERS: 1US FAERS
374Procedural site reactionFAERS: 1US FAERS
375Product quality issueFAERS: 1US FAERS
376Product use issueFAERS: 1US FAERS
377Proteus test positiveFAERS: 1US FAERS
378Pulmonary FibrosisFAERS: 1US FAERS
379Pulmonary artery aneurysmFAERS: 1US FAERS
380Pulmonary artery thrombosisFAERS: 1US FAERS
381Pulmonary function test decreasedFAERS: 1US FAERS
382Pulmonary hilar enlargementFAERS: 1US FAERS
383Pulmonary painFAERS: 1US FAERS
384Pulmonary toxicityFAERS: 1US FAERS
385Purulent dischargeFAERS: 1US FAERS
386Rash erythematousFAERS: 1SIDER
US FAERS
387Renal cell carcinoma recurrentFAERS: 1US FAERS
388Renal cystFAERS: 1US FAERS
389Respiratory syncytial virus test positiveFAERS: 1US FAERS
390Respiratory tract infection fungalFAERS: 1US FAERS
391RestlessnessFAERS: 1US FAERS
392Retinal DetachmentFAERS: 1US FAERS
393Retinal exudatesFAERS: 1US FAERS
394RhabdomyolysisFAERS: 1US FAERS
395RhinitisFAERS: 1US FAERS
396Scleral pigmentationFAERS: 1US FAERS
397SeromaFAERS: 1US FAERS
398Sinus headacheFAERS: 1US FAERS
399Skin ErosionFAERS: 1US FAERS
400Soft tissue necrosisFAERS: 1US FAERS
401Squamous cell carcinoma of skinFAERS: 1US FAERS
402Squamous cell carcinomaFAERS: 1US FAERS
403Staphylococcal osteomyelitisFAERS: 1US FAERS
404Subcutaneous EmphysemaFAERS: 1US FAERS
405Sudden deathFAERS: 1US FAERS
406SwellingFAERS: 1US FAERS
407Thrombotic cerebral infarctionFAERS: 1US FAERS
408Thyroxine therapyFAERS: 1US FAERS
409Tracheal StenosisFAERS: 1US FAERS
410TremorFAERS: 1US FAERS
411TrismusFAERS: 1US FAERS
412Troponin increasedFAERS: 1US FAERS
413Umbilical erythemaFAERS: 1US FAERS
414Upper-airway cough syndromeFAERS: 1US FAERS
415Uterine abscessFAERS: 1US FAERS
416Vaginal FistulaFAERS: 1US FAERS
417Vascular calcificationFAERS: 1US FAERS
418Venous ThrombosisFAERS: 1US FAERS
419WheezingFAERS: 1US FAERS
420abdominal wall woundFAERS: 1US FAERS
421effusionFAERS: 1US FAERS
422nervous system disorderFAERS: 1SIDER
US FAERS
423skin abrasionFAERS: 1US FAERS
424AgeusiaSIDER
425AnorexiaSIDER
426Blood albumin decreasedSIDER
427Blood albumin increasedSIDER
428Blood and lymphatic system disordersSIDER
429Blood cholesterol abnormalSIDER
430Blood glucose decreasedSIDER
431Blood glucose increasedSIDER
432Blood magnesium decreasedSIDER
433Blood phosphorus decreasedSIDER
434Calcium lowSIDER
435Chemical and Drug Induced Liver Injury28437613CTD
436Creatinine increasedSIDER
437CystSIDER
438Exfoliative rashSIDER
439Gastrointestinal PainSIDER
440Glucose decreasedSIDER
441Glucose increasedSIDER
442HypogeusiaSIDER
443Infectious peritonitisSIDER
444InfestationSIDER
445LeukodermaSIDER
446LeukopeniaSIDER
447Long QT Syndrome20832415CTD
448MenorrhagiaSIDER
449Mg reducedSIDER
450Musculoskeletal discomfortSIDER
451Phosphorus lowSIDER
452Plantar erythemaSIDER
453Potassium increasedSIDER
454Protein urine presentSIDER
455PrurigoSIDER
456Restrictive cardiomyopathySIDER
457ShockSIDER
458Sodium decreasedSIDER
459Torsades de Pointes20832415CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.